Pediatric Gastroenteritis

Updated: September 16, 2022

Background

Epidemiology

Anatomy

Pathophysiology

Etiology

Genetics

Prognostic Factors

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

rotavirus oral vaccine, live

RotaTeq(R): A dose of orally 2 mL (using one dosing tube) for a total of three doses, with each dose given at intervals of four to ten weeks
Rotarix(R): a dose of 1 ml orally for two doses, with a minimum interval of four weeks between each administration
start administration at 6 weeks of age, ensure the two-dose program of Rotarix(R) is finished by 24 weeks of age, while the three-dose program of RotaTeq(R) should be finished by 32 weeks

veralipride

For <2 years and <10.9 kg: 20 mg orally 4 times each day as required post-meals and at bedtime
Keep the maximum dose to 240 mg each day
For >10.9 kg: 40 mg orally 4 times each day as required post-meals and at bedtime
Keep the maximum dose to 480 mg each day
For children >12 years: 40-125 mg orally 4 times each day as required post-meals and at bedtime

Future Trends